Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $16 Million Debt Financing Transaction
New York, NY – August 19, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented EF Hutton LLC in a $16 million debt financing transaction between NRx Pharmaceuticals, Inc. (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company and Anson Funds.
EF Hutton LLC acted as the exclusive placement agent for the Financing.
The SRFC team was led by partner Ross Carmel.